IL35788A - '' '3- and' '' 'O-4-pure methyl digoxin and the process for its preparation - Google Patents
'' '3- and' '' 'O-4-pure methyl digoxin and the process for its preparationInfo
- Publication number
- IL35788A IL35788A IL35788A IL3578870A IL35788A IL 35788 A IL35788 A IL 35788A IL 35788 A IL35788 A IL 35788A IL 3578870 A IL3578870 A IL 3578870A IL 35788 A IL35788 A IL 35788A
- Authority
- IL
- Israel
- Prior art keywords
- digoxin
- methyl
- process according
- chloroform
- pure
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 21
- 229960003746 metildigoxin Drugs 0.000 title claims description 15
- 238000002360 preparation method Methods 0.000 title claims description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 34
- 229960005156 digoxin Drugs 0.000 claims description 28
- LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 claims description 27
- LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 claims description 27
- LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 claims description 25
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 18
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 12
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 10
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 claims description 7
- 239000011541 reaction mixture Substances 0.000 claims description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 6
- 238000005192 partition Methods 0.000 claims description 5
- 239000012071 phase Substances 0.000 claims description 5
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 5
- 239000004411 aluminium Substances 0.000 claims description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 4
- 229910052782 aluminium Inorganic materials 0.000 claims description 4
- 239000008346 aqueous phase Substances 0.000 claims description 4
- LMHHRCOWPQNFTF-UHFFFAOYSA-N s-propan-2-yl azepane-1-carbothioate Chemical compound CC(C)SC(=O)N1CCCCCC1 LMHHRCOWPQNFTF-UHFFFAOYSA-N 0.000 claims description 4
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 claims description 3
- 229910001863 barium hydroxide Inorganic materials 0.000 claims description 3
- -1 chloroform-carbon tetrachlor Chemical compound 0.000 claims description 3
- 239000012442 inert solvent Substances 0.000 claims description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 2
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 claims description 2
- IYJMSDVSVHDVGT-PEQKVOOWSA-N metildigoxin Chemical compound O1[C@H](C)[C@@H](OC)[C@@H](O)C[C@@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O IYJMSDVSVHDVGT-PEQKVOOWSA-N 0.000 claims description 2
- 238000007738 vacuum evaporation Methods 0.000 claims 1
- 238000007069 methylation reaction Methods 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical class COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 230000008020 evaporation Effects 0.000 description 4
- 230000011987 methylation Effects 0.000 description 4
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 3
- SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 3
- VHQSXIONDJVXHP-UHFFFAOYSA-N chloroform methanol tetrachloromethane hydrate Chemical compound O.OC.ClC(Cl)Cl.ClC(Cl)(Cl)Cl VHQSXIONDJVXHP-UHFFFAOYSA-N 0.000 description 3
- QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 3
- SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- 238000001953 recrystallisation Methods 0.000 description 3
- FDWRIIDFYSUTDP-KVTDHHQDSA-N (2r,4r,5s,6r)-6-methyloxane-2,4,5-triol Chemical compound C[C@H]1O[C@@H](O)C[C@@H](O)[C@@H]1O FDWRIIDFYSUTDP-KVTDHHQDSA-N 0.000 description 2
- FDWRIIDFYSUTDP-UHFFFAOYSA-N 102850-49-7 Natural products CC1OC(O)CC(O)C1O FDWRIIDFYSUTDP-UHFFFAOYSA-N 0.000 description 2
- JWFRNGYBHLBCMB-UHFFFAOYSA-N D-Canaytose Natural products CC(O)C(O)C(O)CC=O JWFRNGYBHLBCMB-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 1
- GOYBREOSJSERKM-DSYKOEDSSA-N D-cymarose Chemical compound O=CC[C@H](OC)[C@H](O)[C@@H](C)O GOYBREOSJSERKM-DSYKOEDSSA-N 0.000 description 1
- GOYBREOSJSERKM-UHFFFAOYSA-N D-oleandrose Natural products O=CCC(OC)C(O)C(C)O GOYBREOSJSERKM-UHFFFAOYSA-N 0.000 description 1
- NTSBMKIZRSBFTA-AIDOXSFESA-N Digoxigenin bisdigitoxoside Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2C[C@@H]3[C@]([C@@H]4[C@H]([C@]5(CC[C@@H]([C@@]5(C)[C@H](O)C4)C=4COC(=O)C=4)O)CC3)(C)CC2)C[C@@H]1O NTSBMKIZRSBFTA-AIDOXSFESA-N 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 210000002318 cardia Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- NTSBMKIZRSBFTA-UHFFFAOYSA-N digoxingenin bisdigitoxoside Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2CC3C(C4C(C5(CCC(C5(C)C(O)C4)C=4COC(=O)C=4)O)CC3)(C)CC2)CC1O NTSBMKIZRSBFTA-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 150000005217 methyl ethers Chemical class 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 208000016258 weakness Diseases 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J19/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 by a lactone ring
- C07J19/005—Glycosides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Installation Of Indoor Wiring (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19691961034 DE1961034C (de) | 1969-12-05 | Verfahren zur Herstellung von reinen Digoxin-mono-methyläthern |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL35788A0 IL35788A0 (en) | 1971-02-25 |
| IL35788A true IL35788A (en) | 1973-05-31 |
Family
ID=5753066
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL35788A IL35788A (en) | 1969-12-05 | 1970-12-03 | '' '3- and' '' 'O-4-pure methyl digoxin and the process for its preparation |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US3712884A (da) |
| JP (1) | JPS5028957B1 (da) |
| AT (1) | AT302544B (da) |
| BE (1) | BE759912A (da) |
| BG (1) | BG18865A3 (da) |
| CH (1) | CH537378A (da) |
| CS (2) | CS155250B2 (da) |
| DK (2) | DK123354B (da) |
| ES (1) | ES386172A1 (da) |
| FI (2) | FI47183C (da) |
| FR (1) | FR2081328B1 (da) |
| GB (1) | GB1274779A (da) |
| IE (1) | IE34790B1 (da) |
| IL (1) | IL35788A (da) |
| NL (1) | NL166696C (da) |
| NO (1) | NO131297C (da) |
| PL (1) | PL81222B1 (da) |
| RO (1) | RO58835A (da) |
| SE (1) | SE356046B (da) |
| YU (1) | YU34302B (da) |
| ZA (1) | ZA708221B (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2233147A1 (de) * | 1972-07-06 | 1974-01-24 | Boehringer Mannheim Gmbh | Dihydrodigoxin-derivate |
| YU39367B (en) * | 1976-08-20 | 1984-10-31 | Lek Tovarna Farmacevtskih | Process for preparing beta-methyl-digoxine |
| DE3146899A1 (de) * | 1981-11-26 | 1983-06-01 | Boehringer Mannheim Gmbh, 6800 Mannheim | Neue ketale von 3'''-dehydro-cardenolid-tridigitoxosiden, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| US4603196A (en) * | 1983-04-27 | 1986-07-29 | Chemie Linz Aktiengesellschaft | Process for the preparation of β-methyldigoxin |
| US4546097A (en) * | 1983-11-04 | 1985-10-08 | The United States Of America As Represented By The Department Of Health And Human Services | Saponin-based polyether polyols, pharmaceutical compositions and a method of using same |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1643665B1 (de) * | 1967-09-20 | 1971-02-18 | Boehringer Mannheim Gmbh | Neue Digoxinaether und Verfahren zur Herstellung derselben |
-
0
- BE BE759912D patent/BE759912A/xx not_active IP Right Cessation
-
1970
- 1970-11-19 US US00091171A patent/US3712884A/en not_active Expired - Lifetime
- 1970-12-01 CS CS82672*A patent/CS155250B2/cs unknown
- 1970-12-01 CS CS811370A patent/CS155249B2/cs unknown
- 1970-12-02 CH CH1784070A patent/CH537378A/de not_active IP Right Cessation
- 1970-12-02 YU YU2917/70A patent/YU34302B/xx unknown
- 1970-12-03 GB GB57485/70A patent/GB1274779A/en not_active Expired
- 1970-12-03 NL NL7017664.A patent/NL166696C/xx not_active IP Right Cessation
- 1970-12-03 IL IL35788A patent/IL35788A/en unknown
- 1970-12-03 BG BG016193A patent/BG18865A3/xx unknown
- 1970-12-03 RO RO65176A patent/RO58835A/ro unknown
- 1970-12-04 ES ES386172A patent/ES386172A1/es not_active Expired
- 1970-12-04 AT AT1093870A patent/AT302544B/de not_active IP Right Cessation
- 1970-12-04 FI FI703275A patent/FI47183C/fi active
- 1970-12-04 FR FR7043635A patent/FR2081328B1/fr not_active Expired
- 1970-12-04 PL PL1970144818A patent/PL81222B1/pl unknown
- 1970-12-04 DK DK619970AA patent/DK123354B/da not_active IP Right Cessation
- 1970-12-04 ZA ZA708221A patent/ZA708221B/xx unknown
- 1970-12-04 IE IE1556/70A patent/IE34790B1/xx unknown
- 1970-12-04 SE SE16441/70A patent/SE356046B/xx unknown
- 1970-12-04 NO NO4658/70A patent/NO131297C/no unknown
- 1970-12-05 JP JP45108059A patent/JPS5028957B1/ja active Pending
-
1971
- 1971-12-13 DK DK607471AA patent/DK123714B/da not_active IP Right Cessation
-
1973
- 1973-03-06 FI FI730686A patent/FI47574C/fi active
Also Published As
| Publication number | Publication date |
|---|---|
| NL7017664A (da) | 1971-06-08 |
| IE34790B1 (en) | 1975-08-20 |
| DK123714B (da) | 1972-07-24 |
| US3712884A (en) | 1973-01-23 |
| FI47183B (da) | 1973-07-02 |
| NO131297C (da) | 1975-05-07 |
| FI47183C (fi) | 1973-10-10 |
| BE759912A (fr) | 1971-06-04 |
| CS155249B2 (da) | 1974-05-30 |
| ES386172A1 (es) | 1973-03-16 |
| NO131297B (da) | 1975-01-27 |
| NL166696C (nl) | 1981-09-15 |
| DE1961034A1 (de) | 1971-06-09 |
| RO58835A (da) | 1975-11-15 |
| ZA708221B (en) | 1971-10-27 |
| CS155250B2 (da) | 1974-05-30 |
| YU34302B (en) | 1979-04-30 |
| SE356046B (da) | 1973-05-14 |
| IL35788A0 (en) | 1971-02-25 |
| JPS5028957B1 (da) | 1975-09-19 |
| SU373935A3 (da) | 1973-03-12 |
| FR2081328B1 (da) | 1974-08-23 |
| CH537378A (de) | 1973-05-31 |
| IE34790L (en) | 1971-06-05 |
| FI47574B (da) | 1973-10-01 |
| GB1274779A (en) | 1972-05-17 |
| DK123354B (da) | 1972-06-12 |
| BG18865A3 (bg) | 1975-03-20 |
| NL166696B (nl) | 1981-04-15 |
| FI47574C (fi) | 1974-01-10 |
| AT302544B (de) | 1972-10-25 |
| PL81222B1 (da) | 1975-08-30 |
| FR2081328A1 (da) | 1971-12-03 |
| YU291770A (en) | 1978-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Dimler et al. | A New Anhydride of D-Glucose: D-Glucosan< 1, 4> β< 1, 6> | |
| Lemieux | The biochemistry of the Ustilaginales: III. The degradation products and proof of the chemical heterogeneity of ustilagic acid | |
| SU628822A3 (ru) | Способ получени хлоргидрата 4 -эпи-6 оксиадриамицина | |
| Vis et al. | 1, 5-Anhydro-β-D-ribofuranose and the “Monoacetone Anhydroriboses” of Levene and Stiller | |
| US3514441A (en) | Process for preparing steroid-acylates of a cardiac glycoside and products thereof | |
| IL35788A (en) | '' '3- and' '' 'O-4-pure methyl digoxin and the process for its preparation | |
| Bharucha et al. | The conversion of hyodesoxycholic acid to progesterone | |
| JP2584829B2 (ja) | ９（１１）−デヒドロステロイドの製造方法 | |
| DK165790B (da) | Fremgangsmaade til fremstilling af adriamycin-4'-o-derivater eller syreadditionssalte deraf | |
| DE1962757C3 (de) | Evomonosid-Derivate, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittel | |
| CA1133476A (fr) | Procede de preparation de nouveaux aminoglycosides derives de la desoxystreptamine et de leurs sels | |
| US3238197A (en) | 19-nor-20-spiroxa-4, 9(10)-dien-3-one, the corresponding 3, 21-dione and intermediates therefor | |
| Agnello et al. | A Stereospecific Synthesis of C-21-Methylated Corticosteroids1a, d | |
| Kovács et al. | Preparation of acylated pyranoid glycals in neutral aqueous medium by using chromium (II) complexes as reagents | |
| US3074932A (en) | 7-substituted thio steroids | |
| Brimacombe | The acetonation of D-talose | |
| CN115626947B (zh) | 五环三萜类天然产物的合成及其应用 | |
| US3843627A (en) | Process for the isolation of convallatoxin acetonide | |
| US3598811A (en) | Derivatives of 4alpha,8,14-trimethyl-18-nor-5alpha,8alpha,9beta,13alpha,14beta,17alpha-pregnane | |
| CS202582B2 (en) | Process for preparing beta-methyldigoxine | |
| US4603196A (en) | Process for the preparation of β-methyldigoxin | |
| DE1961034C (de) | Verfahren zur Herstellung von reinen Digoxin-mono-methyläthern | |
| US3657228A (en) | Process for the manufacture of 3beta-hydroxy-5beta-cardenolides | |
| US2911411A (en) | Derivatives of dibenzo-cycloheptadiene and a method of preparing same | |
| US3014933A (en) | Manufacture of 19-nortestosterone-17-propionate |